>

Research

  • syringe

    VU testing vaccine against new flu threat

    Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring. Read More

    Sep 19, 2013

  • Vanderbilt University

    VU study brings genome’s ‘dark matter’ into light

    Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer. Read More

    Sep 19, 2013

  • microscope

    Lacy’s crystallographic research achievements recognized

    D. Borden Lacy, Ph.D., associate professor of Pathology, Microbiology and Immunology, and Biochemistry, will receive the 2014 Margaret Etter Award from the American Crystallographic Association (ACA) for outstanding achievement and exceptional potential in crystallographic research demonstrated by a scientist at an early stage of their independent career. Read More

    Sep 19, 2013

  • office recycle can

    The surprising link between social responsibility disclosure and profits

    A study out of Vanderbilt University found that corporations that make social responsibility disclosures beyond the norm tend to make more money. Read More

    Sep 18, 2013

  • Government and medicine

    Vanderbilt Medicine: The sequestration era

    Efforts by the federal government to control the nation’s spiraling budget deficit, including sequestration that took effect on March 1, have created the potential for significant impact to Medicare’s long-standing support for graduate medical education and could limit the ability of the nation’s academic medical centers to care for patients and train the next generation of physicians, says Donald Brady, senior associate dean of Graduate Medical Education for Vanderbilt University School of Medicine. Read More

    Sep 18, 2013

  • Vanderbilt University

    Fishing for new anti-cancer drugs

    Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug. Read More

    Sep 18, 2013

  • apartment block blueprint

    Making mixed-income housing work for the poor

    Mixed-income neighborhoods help improve the safety and wellbeing of low-income residents, but cannot relieve deeply entrenched poverty or provide upward mobility without additional social services and supports, say Peabody and University of Chicago researchers in a new report. Read More

    Sep 17, 2013

  • Vanderbilt University

    Mapping brain membrane proteins

    New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues. Read More

    Sep 16, 2013

  • Benbow

    The Tennessean: We must walk fine line when it comes to testing

    We must make sure that standardized tests actually cover what we all agree is important for children to learn, writes Camilla Benbow, Patricia and Rodes Hart Dean of Education and Human Development. Read More

    Sep 16, 2013

  • Vanderbilt University

    Cancer nanomedicines on target

    Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time. Read More

    Sep 13, 2013

  • Deciphering DNA code

    VU study identifies DNA changes in drug-resistant cancer cells

    Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read More

    Sep 12, 2013

  • Vanderbilt University

    VU tracking drug’s ability to prevent type 1 diabetes

    Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D. Read More

    Sep 12, 2013

  • research default banner

    Two named to National Academies’ advisory board

    Vanderbilt University’s Roger D. Cone, Ph.D., and Elizabeth Heitman, Ph.D., have been appointed to the National Academies’ Board on Life Sciences, which advises the government and scientific community on a wide range of topics, from stem cell research to bioterrorism. Read More

    Sep 12, 2013

  • Vanderbilt University

    Sleep education helps families of children with autism

    Parent sleep education is beneficial in improving sleep and aspects of daytime behavior and family functioning in children with autism spectrum disorders (ASD), according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders. Read More

    Sep 12, 2013

  • Vanderbilt University

    ‘Proofreader’ key to coronavirus growth

    A coronavirus protein is required for replication of the viral genome and may be a good treatment target for SARS and other diseases caused by coronaviruses. Read More

    Sep 12, 2013

  • Vanderbilt University

    Vanderbilt Business: A matter of life and death

    Ensuring patient safety in today's medical environment requires a fundamental shift in today’s health care organizations, says Ranga Ramanujam. Read More

    Sep 11, 2013

  • Tiffiny Tung and skull

    Vanderbilt Magazine: How to study a skeleton

    Tiffiny Tung, associate professor of anthropology, is on familiar terms with the dead. She may not know their names, but she can tell you a surprising amount of information about how they lived—and even, on occasion, how they died. Read More

    Sep 11, 2013

  • Vanderbilt University

    Vanderbilt Medicine: A shining light

    The Aspirnaut program, funded by Billy and Julie Hudson, brings science, technology, engineering and math lessons and labs to rural teachers, students and school districts via video and teleconferencing. Read More

    Sep 11, 2013

  • robot hand

    Vanderbilt Medicine: Robotics revolution

    In the foreseeable future, robots will be sticking steerable needles in your brain to remove blood clots; capsule robots will be crawling up your colon as a painless replacement for the colonoscopy; and ultra-miniaturized snake robots will remove tumors from your bladder and other body cavities. Read More

    Sep 11, 2013

  • Vanderbilt University

    Sarcoidosis research finds promising oral therapy

    VUMC researchers have reported promising results in using oral antimycobacterial therapy to treat chronic cutaneous sarcoidosis, considered by clinicians a difficult illness to effectively control. Read More

    Sep 5, 2013